FDA Inspection 1025610 — University Of Hawaii IRB

University Of Hawaii IRB — FEI 2918531

The FDA completed an inspection of University Of Hawaii IRB on July 14, 2017 in Honolulu, HI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 14, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Honolulu, HI (United States)

Additional Details

IRB